RKIP is a metastasis suppressor that acts along the RAF1/MEK/ERK pathway to regulate cell proliferation and migration in prostate cancer, breast cancer, lung cancer and pancreatic cancer [16–18]. The gene discussed is PEBP1; the disease is breast carcinoma.